SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'WYQ'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDU_B_CIAB2003_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 ALA A 524 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.59A	1uduB-3v94A: 33.5	1uduB-3v94A: 28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UHO_A_VDNA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 10	TYR A 367 HIS A 368 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.41A	1uhoA-3v94A: 34.4	1uhoA-3v94A: 28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 HIS A 413 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.43A	1xlxA-3v94A: 40.1	1xlxA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 413 MET A 482 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.85A	1xlxA-3v94A: 40.1	1xlxA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	8 / 12	TYR A 367 HIS A 368 HIS A 413 MET A 482 ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.77A	1xlxB-3v94A: 39.9	1xlxB-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	7 / 12	TYR A 367 HIS A 368 ASP A 521 TRP A 535 ILE A 538 PHE A 542 PHE A 573	WYQ A 701 (-4.5A) None ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.4A)	0.77A	1xmuA-3v94A: 39.9	1xmuA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 TRP A 535 PHE A 542 SER A 569 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.7A) None WYQ A 701 (-3.4A)	0.94A	1xmuA-3v94A: 39.9	1xmuA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 ASP A 521 TRP A 535 ILE A 538 PHE A 542	WYQ A 701 (-4.5A) None ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A)	0.61A	1xmuB-3v94A: 40.1	1xmuB-3v94A: 27.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	8 / 12	TYR A 367 HIS A 368 MET A 482 ASP A 521 ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) ZN A 702 (-1.9A) WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.81A	1xomA-3v94A: 40.2	1xomA-3v94A: 30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	7 / 12	TYR A 367 HIS A 368 MET A 482 ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.81A	1xomB-3v94A: 40.2	1xomB-3v94A: 30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 HIS A 368 ILE A 538 SER A 569 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 ( 4.1A) None WYQ A 701 (-3.4A)	0.77A	1xoqA-3v94A: 40.1	1xoqA-3v94A: 30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 MET A 482 ASP A 521 ILE A 538 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) ZN A 702 (-1.9A) WYQ A 701 ( 4.1A) WYQ A 701 (-3.4A)	0.76A	1xoqA-3v94A: 40.1	1xoqA-3v94A: 30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 ASP A 521 TRP A 535 ILE A 538 PHE A 573	WYQ A 701 (-4.5A) None ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.4A)	0.71A	1xoqB-3v94A: 40.0	1xoqB-3v94A: 30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	MET A 482 ASP A 521 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) ZN A 702 (-1.9A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.97A	1xosA-3v94A: 40.0	1xosA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 ASP A 521 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None ZN A 702 (-1.9A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.74A	1xosA-3v94A: 40.0	1xosA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 HIS A 368 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.32A	1xotA-3v94A: 40.0	1xotA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 MET A 482 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.76A	1xotA-3v94A: 40.0	1xotA-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 HIS A 368 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.34A	1xotB-3v94A: 40.1	1xotB-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 MET A 482 ILE A 538 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.84A	1xotB-3v94A: 40.1	1xotB-3v94A: 27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOZ_A_CIAA501_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 ALA A 524 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.68A	1xozA-3v94A: 37.1	1xozA-3v94A: 27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 11	TYR A 367 HIS A 368 ALA A 524 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.78A	2h42A-3v94A: 34.4	2h42A-3v94A: 27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_B_VIAB902_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 12	TYR A 367 HIS A 368 ALA A 524 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.69A	2h42B-3v94A: 34.2	2h42B-3v94A: 27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	7 / 12	TYR A 367 HIS A 368 ILE A 538 GLU A 541 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 ( 4.1A) None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.89A	2weyA-3v94A: 37.8	2weyA-3v94A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	4 / 8	ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.74A	2weyB-3v94A: 37.6	2weyB-3v94A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 ALA A 524 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.77A	3b2rA-3v94A: 30.3	3b2rA-3v94A: 28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 11	TYR A 367 HIS A 368 ALA A 524 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.66A	3b2rB-3v94A: 30.2	3b2rB-3v94A: 28.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 MET A 482 TRP A 535 ILE A 538 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.4A)	0.75A	3g4lA-3v94A: 39.7	3g4lA-3v94A: 30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	7 / 12	TYR A 367 HIS A 368 MET A 482 ASP A 521 TRP A 535 ILE A 538 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.4A)	0.78A	3g4lB-3v94A: 39.8	3g4lB-3v94A: 30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 12	TYR A 367 HIS A 368 MET A 482 ASP A 521 TRP A 535 ILE A 538	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A)	0.63A	3g4lC-3v94A: 39.7	3g4lC-3v94A: 30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	3 / 3	SER A 569 GLN A 570 PHE A 573	None WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.56A	3g4lC-3v94A: 39.7	3g4lC-3v94A: 30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	7 / 12	TYR A 367 HIS A 368 MET A 482 ASP A 521 TRP A 535 ILE A 538 GLN A 570	WYQ A 701 (-4.5A) None WYQ A 701 (-4.5A) ZN A 702 (-1.9A) None WYQ A 701 ( 4.1A) WYQ A 701 (-3.3A)	0.73A	3g4lD-3v94A: 39.8	3g4lD-3v94A: 30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 9	TYR A 367 MET A 482 ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.52A	3iakA-3v94A: 39.9	3iakA-3v94A: 30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_B_VIAB901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 11	TYR A 367 HIS A 368 ALA A 524 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.71A	3jwqB-3v94A: 36.9 3jwqC-3v94A: 37.0	3jwqB-3v94A: 27.67 3jwqC-3v94A: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	4 / 7	TYR A 367 HIS A 368 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.48A	3jwqC-3v94A: 37.0	3jwqC-3v94A: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_D_VIAD901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	6 / 11	TYR A 367 HIS A 368 ALA A 524 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) None None WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.74A	3jwqA-3v94A: 37.0 3jwqD-3v94A: 36.8	3jwqA-3v94A: 27.67 3jwqD-3v94A: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGL_A_GLYA301_0 (GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	4 / 8	ALA A 419 THR A 417 GLN A 545 THR A 557	None WYQ A 701 (-4.5A) None None	0.83A	3rglA-3v94A: undetectable	3rglA-3v94A: 23.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	5 / 7	TYR A 367 ILE A 538 PHE A 542 GLN A 570 PHE A 573	WYQ A 701 (-4.5A) WYQ A 701 ( 4.1A) WYQ A 701 (-4.7A) WYQ A 701 (-3.3A) WYQ A 701 (-3.4A)	0.55A	3tvxB-3v94A: 39.8	3tvxB-3v94A: 30.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UJ7_B_SAMB302_1 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	3v94	CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE (Trypanosoma cruzi)	4 / 5	TYR A 367 SER A 525 ASP A 521 ASP A 481	WYQ A 701 (-4.5A) None ZN A 702 (-1.9A) None	1.35A	3uj7B-3v94A: undetectable	3uj7B-3v94A: 21.13

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UDU_B_CIAB2003_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;ALA A 524;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.59A","1uduB-3v94A:33.5",null],["1UHO_A_VDNA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.41A","1uhoA-3v94A:34.4","1uduB-3v94A:28.12"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;HIS A 413;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.43A","1xlxA-3v94A:40.1","1uhoA-3v94A:28.12"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 413;MET A 482;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.85A","1xlxA-3v94A:40.1","1xlxA-3v94A:27.11"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",8,"TYR A 367;HIS A 368;HIS A 413;MET A 482;ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.77A","1xlxB-3v94A:39.9","1xlxA-3v94A:27.11"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",7,"TYR A 367;HIS A 368;ASP A 521;TRP A 535;ILE A 538;PHE A 542;PHE A 573","WYQ A 701 (-4.5A);None; ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.4A)","0.77A","1xmuA-3v94A:39.9","1xlxB-3v94A:27.11"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;TRP A 535;PHE A 542;SER A 569;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.7A);None;WYQ A 701 (-3.4A)","0.94A","1xmuA-3v94A:39.9","1xmuA-3v94A:27.11"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ASP A 521;TRP A 535;ILE A 538;PHE A 542","WYQ A 701 (-4.5A);None; ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A)","0.61A","1xmuB-3v94A:40.1","1xmuA-3v94A:27.11"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",8,"TYR A 367;HIS A 368;MET A 482;ASP A 521;ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A); ZN A 702 (-1.9A);WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.81A","1xomA-3v94A:40.2","1xmuB-3v94A:27.11"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",7,"TYR A 367;HIS A 368;MET A 482;ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.81A","1xomB-3v94A:40.2","1xomA-3v94A:30.62"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ILE A 538;SER A 569;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 ( 4.1A);None;WYQ A 701 (-3.4A)","0.77A","1xoqA-3v94A:40.1","1xomB-3v94A:30.62"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;MET A 482;ASP A 521;ILE A 538;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A); ZN A 702 (-1.9A);WYQ A 701 ( 4.1A);WYQ A 701 (-3.4A)","0.76A","1xoqA-3v94A:40.1","1xoqA-3v94A:30.62"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ASP A 521;TRP A 535;ILE A 538;PHE A 573","WYQ A 701 (-4.5A);None; ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.4A)","0.71A","1xoqB-3v94A:40.0","1xoqA-3v94A:30.62"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"MET A 482;ASP A 521;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A); ZN A 702 (-1.9A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.97A","1xosA-3v94A:40.0","1xoqB-3v94A:30.62"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ASP A 521;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None; ZN A 702 (-1.9A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.74A","1xosA-3v94A:40.0","1xosA-3v94A:27.11"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.32A","1xotA-3v94A:40.0","1xosA-3v94A:27.11"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;MET A 482;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.76A","1xotA-3v94A:40.0","1xotA-3v94A:27.11"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.34A","1xotB-3v94A:40.1","1xotA-3v94A:27.11"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;MET A 482;ILE A 538;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.84A","1xotB-3v94A:40.1","1xotB-3v94A:27.11"],["1XOZ_A_CIAA501_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;ALA A 524;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.68A","1xozA-3v94A:37.1","1xotB-3v94A:27.11"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ALA A 524;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.78A","2h42A-3v94A:34.4","1xozA-3v94A:27.79"],["2H42_B_VIAB902_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ALA A 524;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.69A","2h42B-3v94A:34.2","2h42A-3v94A:27.35"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",7,"TYR A 367;HIS A 368;ILE A 538;GLU A 541;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 ( 4.1A);None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.89A","2weyA-3v94A:37.8","2h42B-3v94A:27.35"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",4,"ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.74A","2weyB-3v94A:37.6","2weyA-3v94A:25.00"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ALA A 524;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.77A","3b2rA-3v94A:30.3","2weyB-3v94A:25.00"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ALA A 524;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.66A","3b2rB-3v94A:30.2","3b2rA-3v94A:28.45"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;MET A 482;TRP A 535;ILE A 538;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.4A)","0.75A","3g4lA-3v94A:39.7","3b2rB-3v94A:28.45"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",7,"TYR A 367;HIS A 368;MET A 482;ASP A 521;TRP A 535;ILE A 538;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A); ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.4A)","0.78A","3g4lB-3v94A:39.8","3g4lA-3v94A:30.28"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;MET A 482;ASP A 521;TRP A 535;ILE A 538","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A); ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A)","0.63A","3g4lC-3v94A:39.7","3g4lB-3v94A:30.28"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",3,"SER A 569;GLN A 570;PHE A 573","None;WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.56A","3g4lC-3v94A:39.7","3g4lC-3v94A:30.28"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",7,"TYR A 367;HIS A 368;MET A 482;ASP A 521;TRP A 535;ILE A 538;GLN A 570","WYQ A 701 (-4.5A);None;WYQ A 701 (-4.5A); ZN A 702 (-1.9A);None;WYQ A 701 ( 4.1A);WYQ A 701 (-3.3A)","0.73A","3g4lD-3v94A:39.8","3g4lC-3v94A:30.28"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;MET A 482;ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.52A","3iakA-3v94A:39.9","3g4lD-3v94A:30.28"],["3JWQ_B_VIAB901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;HIS A 368;ALA A 524;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.71A","3jwqB-3v94A:36.9;3jwqC-3v94A:37.0","3iakA-3v94A:30.62"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",4,"TYR A 367;HIS A 368;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.48A","3jwqC-3v94A:37.0","3jwqB-3v94A:27.67;3jwqC-3v94A:27.67"],["3JWQ_D_VIAD901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",6,"TYR A 367;HIS A 368;ALA A 524;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);None;None;WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.74A","3jwqA-3v94A:37.0;3jwqD-3v94A:36.8","3jwqC-3v94A:27.67"],["3RGL_A_GLYA301_0","GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",4,"ALA A 419;THR A 417;GLN A 545;THR A 557","None;WYQ A 701 (-4.5A);None;None","0.83A","3rglA-3v94A:undetectable","3jwqA-3v94A:27.67;3jwqD-3v94A:27.67"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",5,"TYR A 367;ILE A 538;PHE A 542;GLN A 570;PHE A 573","WYQ A 701 (-4.5A);WYQ A 701 ( 4.1A);WYQ A 701 (-4.7A);WYQ A 701 (-3.3A);WYQ A 701 (-3.4A)","0.55A","3tvxB-3v94A:39.8","3rglA-3v94A:23.32"],["3UJ7_B_SAMB302_1","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","3v94","CYCLIC NUCLEOTIDE SPECIFIC PHOSPHODIESTERASE","Trypanosoma cruzi",4,"TYR A 367;SER A 525;ASP A 521;ASP A 481","WYQ A 701 (-4.5A);None; ZN A 702 (-1.9A);None","1.35A","3uj7B-3v94A:undetectable","3tvxB-3v94A:30.71"]]